Structure

Physi-Chem Properties

Molecular Weight:  414.13
Volume:  404.072
LogP:  1.655
LogD:  1.985
LogS:  -4.409
# Rotatable Bonds:  7
TPSA:  89.52
# H-Bond Aceptor:  8
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.683
Synthetic Accessibility Score:  3.035
Fsp3:  0.364
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.784
MDCK Permeability:  3.2284431654261425e-05
Pgp-inhibitor:  0.03
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.009
30% Bioavailability (F30%):  0.093

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.029
Plasma Protein Binding (PPB):  95.41593170166016%
Volume Distribution (VD):  0.688
Pgp-substrate:  3.802323341369629%

ADMET: Metabolism

CYP1A2-inhibitor:  0.275
CYP1A2-substrate:  0.926
CYP2C19-inhibitor:  0.951
CYP2C19-substrate:  0.825
CYP2C9-inhibitor:  0.428
CYP2C9-substrate:  0.916
CYP2D6-inhibitor:  0.27
CYP2D6-substrate:  0.889
CYP3A4-inhibitor:  0.933
CYP3A4-substrate:  0.797

ADMET: Excretion

Clearance (CL):  10.313
Half-life (T1/2):  0.27

ADMET: Toxicity

hERG Blockers:  0.353
Human Hepatotoxicity (H-HT):  0.551
Drug-inuced Liver Injury (DILI):  0.823
AMES Toxicity:  0.024
Rat Oral Acute Toxicity:  0.042
Maximum Recommended Daily Dose:  0.029
Skin Sensitization:  0.126
Carcinogencity:  0.929
Eye Corrosion:  0.003
Eye Irritation:  0.191
Respiratory Toxicity:  0.032

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC87295

Natural Product ID:  NPC87295
Common Name*:   Neglignan C
IUPAC Name:   1-[7-methoxy-6-[4-methoxy-6-(2-oxopropyl)-1,3-benzodioxol-5-yl]-1,3-benzodioxol-5-yl]propan-2-one
Synonyms:  
Standard InCHIKey:  VSTIJDYPLCUJNX-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C22H22O8/c1-11(23)5-13-7-15-19(29-9-27-15)21(25-3)17(13)18-14(6-12(2)24)8-16-20(22(18)26-4)30-10-28-16/h7-8H,5-6,9-10H2,1-4H3
SMILES:  COc1c(c(CC(=O)C)cc2c1OCO2)c1c(CC(=O)C)cc2c(c1OC)OCO2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2386331
PubChem CID:   71726088
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29191 Schisandra neglecta Species Schisandraceae Eukaryota Stems Luoji Mountain Village, Xichang County, Sicuan Province, China 2011-Sep PMID[23738539]
NPO29191 Schisandra neglecta Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 = 54500.0 nM PMID[463264]
NPT2678 Cell Line NB-4 Homo sapiens IC50 = 7300.0 nM PMID[463264]
NPT81 Cell Line A549 Homo sapiens IC50 > 6500.0 nM PMID[463264]
NPT83 Cell Line MCF7 Homo sapiens IC50 > 10000.0 nM PMID[463264]
NPT306 Cell Line PC-3 Homo sapiens IC50 > 10000.0 nM PMID[463264]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 8200.0 nM PMID[463264]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 3900.0 nM PMID[463264]
NPT27 Others Unspecified Ratio CC50/EC50 = 14.1 n.a. PMID[463264]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC87295 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9348 High Similarity NPC471182
0.9315 High Similarity NPC104353
0.9184 High Similarity NPC220577
0.9172 High Similarity NPC304821
0.9116 High Similarity NPC303519
0.9067 High Similarity NPC477380
0.906 High Similarity NPC273578
0.9013 High Similarity NPC474770
0.9007 High Similarity NPC477885
0.8993 High Similarity NPC474514
0.8961 High Similarity NPC475865
0.8958 High Similarity NPC474288
0.8947 High Similarity NPC325122
0.8936 High Similarity NPC32189
0.8933 High Similarity NPC178195
0.8933 High Similarity NPC348849
0.8919 High Similarity NPC149505
0.8896 High Similarity NPC61141
0.8889 High Similarity NPC40237
0.8889 High Similarity NPC151423
0.8859 High Similarity NPC474975
0.8859 High Similarity NPC13985
0.8859 High Similarity NPC210642
0.8794 High Similarity NPC185680
0.8794 High Similarity NPC145722
0.8794 High Similarity NPC256776
0.8776 High Similarity NPC296575
0.8776 High Similarity NPC321696
0.8776 High Similarity NPC321958
0.8774 High Similarity NPC469512
0.8767 High Similarity NPC92693
0.8767 High Similarity NPC18211
0.8767 High Similarity NPC143092
0.8767 High Similarity NPC218841
0.8767 High Similarity NPC475000
0.8759 High Similarity NPC176586
0.8759 High Similarity NPC210354
0.8758 High Similarity NPC474990
0.875 High Similarity NPC216434
0.875 High Similarity NPC103448
0.8725 High Similarity NPC85141
0.8718 High Similarity NPC469475
0.8718 High Similarity NPC469518
0.8716 High Similarity NPC80230
0.8716 High Similarity NPC304687
0.8716 High Similarity NPC101755
0.8716 High Similarity NPC104024
0.8716 High Similarity NPC65574
0.871 High Similarity NPC258322
0.871 High Similarity NPC191352
0.8707 High Similarity NPC318286
0.8707 High Similarity NPC474158
0.8707 High Similarity NPC327651
0.8701 High Similarity NPC474043
0.8701 High Similarity NPC125713
0.8699 High Similarity NPC218510
0.8699 High Similarity NPC76415
0.8684 High Similarity NPC57211
0.8671 High Similarity NPC11453
0.8662 High Similarity NPC477884
0.8649 High Similarity NPC224687
0.8649 High Similarity NPC193779
0.8643 High Similarity NPC258483
0.8639 High Similarity NPC177644
0.8639 High Similarity NPC326144
0.8639 High Similarity NPC191158
0.8636 High Similarity NPC19947
0.8636 High Similarity NPC207584
0.863 High Similarity NPC474295
0.8627 High Similarity NPC202249
0.8627 High Similarity NPC42871
0.8627 High Similarity NPC188962
0.8618 High Similarity NPC52623
0.8609 High Similarity NPC234152
0.86 High Similarity NPC477698
0.86 High Similarity NPC262455
0.86 High Similarity NPC177476
0.859 High Similarity NPC209411
0.859 High Similarity NPC239890
0.8581 High Similarity NPC475868
0.8571 High Similarity NPC32373
0.8571 High Similarity NPC237946
0.8571 High Similarity NPC301897
0.8562 High Similarity NPC478213
0.8553 High Similarity NPC279061
0.8552 High Similarity NPC201404
0.8552 High Similarity NPC290714
0.8552 High Similarity NPC53722
0.8552 High Similarity NPC470962
0.8543 High Similarity NPC473989
0.8543 High Similarity NPC316989
0.8533 High Similarity NPC262804
0.8533 High Similarity NPC40654
0.8533 High Similarity NPC327352
0.8533 High Similarity NPC198129
0.8533 High Similarity NPC477375
0.8533 High Similarity NPC252281
0.8526 High Similarity NPC96593
0.8521 High Similarity NPC65183
0.8521 High Similarity NPC261812
0.8521 High Similarity NPC72046
0.8516 High Similarity NPC181168
0.8516 High Similarity NPC163527
0.8516 High Similarity NPC115281
0.8514 High Similarity NPC474036
0.8514 High Similarity NPC172171
0.8514 High Similarity NPC239254
0.8509 High Similarity NPC178737
0.8506 High Similarity NPC238834
0.8506 High Similarity NPC478238
0.8506 High Similarity NPC234730
0.8497 Intermediate Similarity NPC153008
0.8497 Intermediate Similarity NPC148497
0.8497 Intermediate Similarity NPC68882
0.8497 Intermediate Similarity NPC245948
0.8491 Intermediate Similarity NPC474042
0.8491 Intermediate Similarity NPC174734
0.8487 Intermediate Similarity NPC164082
0.8483 Intermediate Similarity NPC196420
0.8477 Intermediate Similarity NPC322426
0.8477 Intermediate Similarity NPC293757
0.8477 Intermediate Similarity NPC477374
0.8477 Intermediate Similarity NPC668
0.8477 Intermediate Similarity NPC474965
0.8477 Intermediate Similarity NPC477695
0.8477 Intermediate Similarity NPC477376
0.8477 Intermediate Similarity NPC174512
0.8472 Intermediate Similarity NPC148893
0.8472 Intermediate Similarity NPC49235
0.8472 Intermediate Similarity NPC72796
0.8472 Intermediate Similarity NPC150534
0.8472 Intermediate Similarity NPC44245
0.8472 Intermediate Similarity NPC25333
0.8471 Intermediate Similarity NPC288149
0.8471 Intermediate Similarity NPC319749
0.8462 Intermediate Similarity NPC266848
0.8462 Intermediate Similarity NPC136750
0.8457 Intermediate Similarity NPC474568
0.8452 Intermediate Similarity NPC155063
0.8452 Intermediate Similarity NPC115123
0.8452 Intermediate Similarity NPC239113
0.8451 Intermediate Similarity NPC192255
0.8447 Intermediate Similarity NPC477883
0.8446 Intermediate Similarity NPC324962
0.8442 Intermediate Similarity NPC312763
0.8442 Intermediate Similarity NPC198461
0.844 Intermediate Similarity NPC150809
0.8438 Intermediate Similarity NPC42230
0.8438 Intermediate Similarity NPC474948
0.8438 Intermediate Similarity NPC79322
0.8438 Intermediate Similarity NPC471180
0.8435 Intermediate Similarity NPC312199
0.8431 Intermediate Similarity NPC56184
0.8431 Intermediate Similarity NPC477699
0.8428 Intermediate Similarity NPC474647
0.8428 Intermediate Similarity NPC475953
0.8428 Intermediate Similarity NPC187923
0.8425 Intermediate Similarity NPC9068
0.8421 Intermediate Similarity NPC475170
0.8418 Intermediate Similarity NPC280778
0.8414 Intermediate Similarity NPC143895
0.8414 Intermediate Similarity NPC121651
0.8411 Intermediate Similarity NPC316676
0.8411 Intermediate Similarity NPC325720
0.8408 Intermediate Similarity NPC131557
0.8408 Intermediate Similarity NPC150943
0.8408 Intermediate Similarity NPC91634
0.8408 Intermediate Similarity NPC268718
0.8408 Intermediate Similarity NPC119910
0.8403 Intermediate Similarity NPC31530
0.84 Intermediate Similarity NPC154971
0.84 Intermediate Similarity NPC252286
0.8397 Intermediate Similarity NPC258644
0.8395 Intermediate Similarity NPC469506
0.8392 Intermediate Similarity NPC7744
0.8387 Intermediate Similarity NPC284353
0.8385 Intermediate Similarity NPC117911
0.8378 Intermediate Similarity NPC36531
0.8378 Intermediate Similarity NPC184641
0.8378 Intermediate Similarity NPC229172
0.8378 Intermediate Similarity NPC287124
0.8378 Intermediate Similarity NPC230538
0.8378 Intermediate Similarity NPC133934
0.8378 Intermediate Similarity NPC184684
0.8378 Intermediate Similarity NPC103637
0.8377 Intermediate Similarity NPC144162
0.8377 Intermediate Similarity NPC474606
0.8377 Intermediate Similarity NPC308555
0.8377 Intermediate Similarity NPC292460
0.8366 Intermediate Similarity NPC163002
0.8366 Intermediate Similarity NPC477700
0.8366 Intermediate Similarity NPC475756
0.8356 Intermediate Similarity NPC261714
0.8356 Intermediate Similarity NPC283949
0.8355 Intermediate Similarity NPC472567
0.8355 Intermediate Similarity NPC476058
0.8355 Intermediate Similarity NPC145569
0.8355 Intermediate Similarity NPC216223
0.8354 Intermediate Similarity NPC196771
0.8354 Intermediate Similarity NPC152424

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC87295 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8658 High Similarity NPD6980 Clinical (unspecified phase)
0.8571 High Similarity NPD4967 Phase 2
0.8571 High Similarity NPD4966 Approved
0.8571 High Similarity NPD4965 Approved
0.8497 Intermediate Similarity NPD37 Approved
0.8471 Intermediate Similarity NPD7199 Phase 2
0.8462 Intermediate Similarity NPD6234 Discontinued
0.8365 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8098 Intermediate Similarity NPD7228 Approved
0.8092 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3705 Approved
0.7988 Intermediate Similarity NPD3818 Discontinued
0.7963 Intermediate Similarity NPD6232 Discontinued
0.7927 Intermediate Similarity NPD7473 Discontinued
0.7904 Intermediate Similarity NPD7240 Approved
0.784 Intermediate Similarity NPD5494 Approved
0.7812 Intermediate Similarity NPD3817 Phase 2
0.7805 Intermediate Similarity NPD3926 Phase 2
0.7784 Intermediate Similarity NPD7074 Phase 3
0.7725 Intermediate Similarity NPD7054 Approved
0.7688 Intermediate Similarity NPD1934 Approved
0.7679 Intermediate Similarity NPD7472 Approved
0.7654 Intermediate Similarity NPD3882 Suspended
0.764 Intermediate Similarity NPD2801 Approved
0.764 Intermediate Similarity NPD1465 Phase 2
0.7619 Intermediate Similarity NPD5844 Phase 1
0.7561 Intermediate Similarity NPD919 Approved
0.7551 Intermediate Similarity NPD3018 Phase 2
0.7546 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD7808 Phase 3
0.7531 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD7819 Suspended
0.7529 Intermediate Similarity NPD6797 Phase 2
0.7517 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7251 Discontinued
0.747 Intermediate Similarity NPD1247 Approved
0.7457 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD3748 Approved
0.745 Intermediate Similarity NPD3027 Phase 3
0.7448 Intermediate Similarity NPD2981 Phase 2
0.7442 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD6166 Phase 2
0.744 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD3787 Discontinued
0.7419 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD1651 Approved
0.7405 Intermediate Similarity NPD1511 Approved
0.7403 Intermediate Similarity NPD2796 Approved
0.7397 Intermediate Similarity NPD2982 Phase 2
0.7397 Intermediate Similarity NPD2983 Phase 2
0.7384 Intermediate Similarity NPD6559 Discontinued
0.7358 Intermediate Similarity NPD2533 Approved
0.7358 Intermediate Similarity NPD2534 Approved
0.7358 Intermediate Similarity NPD2532 Approved
0.7357 Intermediate Similarity NPD5283 Phase 1
0.7346 Intermediate Similarity NPD7028 Phase 2
0.7321 Intermediate Similarity NPD7229 Phase 3
0.7312 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD1512 Approved
0.7303 Intermediate Similarity NPD1240 Approved
0.7296 Intermediate Similarity NPD6799 Approved
0.729 Intermediate Similarity NPD6100 Approved
0.729 Intermediate Similarity NPD2438 Suspended
0.729 Intermediate Similarity NPD6099 Approved
0.7278 Intermediate Similarity NPD5242 Approved
0.7273 Intermediate Similarity NPD5536 Phase 2
0.7262 Intermediate Similarity NPD6959 Discontinued
0.7261 Intermediate Similarity NPD1243 Approved
0.726 Intermediate Similarity NPD1281 Approved
0.7253 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD17 Approved
0.7239 Intermediate Similarity NPD4380 Phase 2
0.7239 Intermediate Similarity NPD6599 Discontinued
0.7228 Intermediate Similarity NPD5006 Approved
0.7228 Intermediate Similarity NPD5005 Approved
0.7226 Intermediate Similarity NPD1510 Phase 2
0.7215 Intermediate Similarity NPD3750 Approved
0.7209 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD1607 Approved
0.72 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD2979 Phase 3
0.717 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD920 Approved
0.7152 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD3751 Discontinued
0.7143 Intermediate Similarity NPD1933 Approved
0.7126 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD1283 Approved
0.7108 Intermediate Similarity NPD8455 Phase 2
0.7108 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD4420 Approved
0.7097 Intermediate Similarity NPD7680 Approved
0.7095 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD1608 Approved
0.7083 Intermediate Similarity NPD7075 Discontinued
0.7083 Intermediate Similarity NPD3749 Approved
0.7078 Intermediate Similarity NPD1613 Approved
0.7078 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD3539 Phase 1
0.7066 Intermediate Similarity NPD5353 Approved
0.7048 Intermediate Similarity NPD6801 Discontinued
0.7044 Intermediate Similarity NPD6674 Discontinued
0.7044 Intermediate Similarity NPD2654 Approved
0.7037 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD230 Phase 1
0.7025 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD3540 Phase 1
0.7025 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD1653 Approved
0.7 Intermediate Similarity NPD1876 Approved
0.6989 Remote Similarity NPD7685 Pre-registration
0.6988 Remote Similarity NPD6385 Approved
0.6988 Remote Similarity NPD7411 Suspended
0.6988 Remote Similarity NPD6386 Approved
0.6981 Remote Similarity NPD1549 Phase 2
0.698 Remote Similarity NPD3972 Approved
0.6975 Remote Similarity NPD7390 Discontinued
0.697 Remote Similarity NPD7458 Discontinued
0.6968 Remote Similarity NPD943 Approved
0.6964 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6962 Remote Similarity NPD2935 Discontinued
0.6957 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6951 Remote Similarity NPD6662 Clinical (unspecified phase)
0.6937 Remote Similarity NPD2800 Approved
0.6933 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6933 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6928 Remote Similarity NPD6875 Approved
0.6928 Remote Similarity NPD6876 Approved
0.6923 Remote Similarity NPD6355 Discontinued
0.6923 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6908 Remote Similarity NPD2798 Approved
0.6894 Remote Similarity NPD4110 Phase 3
0.6894 Remote Similarity NPD4628 Phase 3
0.6894 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6894 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6886 Remote Similarity NPD5090 Approved
0.6886 Remote Similarity NPD5089 Approved
0.6883 Remote Similarity NPD4625 Phase 3
0.6882 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6882 Remote Similarity NPD4055 Discovery
0.6871 Remote Similarity NPD4357 Discontinued
0.6867 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5402 Approved
0.6864 Remote Similarity NPD5978 Approved
0.6864 Remote Similarity NPD5977 Approved
0.6855 Remote Similarity NPD2531 Phase 2
0.6842 Remote Similarity NPD3266 Approved
0.6842 Remote Similarity NPD3267 Approved
0.6839 Remote Similarity NPD2403 Approved
0.6839 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6832 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6829 Remote Similarity NPD3146 Approved
0.6829 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6824 Remote Similarity NPD1357 Approved
0.6823 Remote Similarity NPD8151 Discontinued
0.6821 Remote Similarity NPD5711 Approved
0.6821 Remote Similarity NPD5710 Approved
0.6818 Remote Similarity NPD4908 Phase 1
0.681 Remote Similarity NPD7124 Phase 2
0.6805 Remote Similarity NPD4585 Approved
0.6795 Remote Similarity NPD8032 Phase 2
0.6792 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6792 Remote Similarity NPD651 Clinical (unspecified phase)
0.679 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6786 Remote Similarity NPD7109 Clinical (unspecified phase)
0.6786 Remote Similarity NPD7110 Phase 1
0.6772 Remote Similarity NPD6651 Approved
0.6766 Remote Similarity NPD4005 Discontinued
0.6766 Remote Similarity NPD3226 Approved
0.6763 Remote Similarity NPD8127 Discontinued
0.6758 Remote Similarity NPD6841 Approved
0.6758 Remote Similarity NPD6843 Phase 3
0.6758 Remote Similarity NPD6842 Approved
0.6752 Remote Similarity NPD4060 Phase 1
0.6748 Remote Similarity NPD6190 Approved
0.6747 Remote Similarity NPD5403 Approved
0.6739 Remote Similarity NPD7296 Approved
0.6731 Remote Similarity NPD5110 Phase 2
0.6731 Remote Similarity NPD6798 Discontinued
0.6731 Remote Similarity NPD5111 Phase 2
0.6731 Remote Similarity NPD5109 Approved
0.6731 Remote Similarity NPD3268 Approved
0.6731 Remote Similarity NPD1296 Phase 2
0.6731 Remote Similarity NPD4907 Clinical (unspecified phase)
0.673 Remote Similarity NPD6111 Discontinued
0.6727 Remote Similarity NPD5401 Approved
0.6725 Remote Similarity NPD7768 Phase 2
0.6711 Remote Similarity NPD5691 Approved
0.671 Remote Similarity NPD6832 Phase 2
0.6709 Remote Similarity NPD447 Suspended
0.6708 Remote Similarity NPD2344 Approved
0.6708 Remote Similarity NPD7266 Discontinued
0.6689 Remote Similarity NPD1610 Phase 2
0.6689 Remote Similarity NPD1611 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data